Chuck Padala | LifeSci Advisors |
Dror Bashan | President & Chief Executive Officer |
Eyal Rubin | Senior Vice President & Chief Financial Officer |
Boobalan Pachaiyappan | H.C. Wainwright |
John Vandermosten | Zacks Investments |
Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics First Quarter 2021 Financial and Business Results Conference Call.
As a reminder, this conference call is being recorded. I will now turn the conference over to our host, Mr. Chuck Padala of LifeSci Advisors Investor Relations. Chuck, you may now begin the presentation.